Search - tctmd.com

Displaying 201 - 220 of 925

Sort: Relevancy | Date

Study Lays Groundwork for Pivotal Trial of Impella CP for LV Unloading Before PCI

News Conference News AHA 2018

Study Lays Groundwork for Pivotal Trial of Impella CP for LV Unloading Before PCI

November 11, 2018

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

News Conference News VIVA 2018

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

November 09, 2018

Attacking DVT With Drug-Device Combo Does Not Reduce Postthrombotic Syndrome

News Conference News VIVA 2018

VERNACULAR: A Novel Venous Stent Shows Promise for Treatment of Iliofemoral Occlusive Disease

November 08, 2018

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

News Daily News

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

November 02, 2018

A Look Back at TCT 2018: What I Took Away From the Meeting

News Opinion Fellow Talk

A Look Back at TCT 2018: What I Took Away From the Meeting

Yashasvi Chugh, MD

October 23, 2018

FDA Approves BioMimics 3D Stent for Femoropopliteal Artery Disease

News Daily News

FDA Approves BioMimics 3D Stent for Femoropopliteal Artery Disease

October 05, 2018

News Industry News

Veryan Medical receives PMA approval for BioMimics 3D

October 05, 2018

Prosthetic Valve Endocarditis Rate Similarly Low for TAVR vs SAVR

News Conference News TCT 2018

Prosthetic Valve Endocarditis Rate Similarly Low for TAVR vs SAVR

TCT Daily Staff

September 28, 2018

Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released

News Conference News TCT 2018

Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released

September 24, 2018

IMPERIAL: Eluvia Tops Zilver PTX in Battle of DES in Femoropopliteal Disease

News Conference News TCT 2018

IMPERIAL: Eluvia Tops Zilver PTX in Battle of DES in Femoropopliteal Disease

September 22, 2018

TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents

News Opinion Editor's Corner TCT 2018

TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents

September 22, 2018

Radial Access Doubled for Left Main PCI in the UK Between 2007 and 2014

News Conference News TCT 2018

Radial Access Doubled for Left Main PCI in the UK Between 2007 and 2014

Yael L. Maxwell

September 21, 2018

Gender Gap Still Wide Open as US Data Show Men Have Consistently Better PCI Outcomes

News Daily News

Gender Gap Still Wide Open as US Data Show Men Have Consistently Better PCI Outcomes

September 14, 2018

MATRIX: 1-Year Results Confirm Superiority of Transradial PCI

News Conference News ESC 2018

MATRIX: 1-Year Results Confirm Superiority of Transradial PCI

Michael O'Riordan

August 25, 2018

No Benefits, Higher Costs With IVC Filters in Catheter-Directed Thrombolysis for DVT

News Daily News

No Benefits, Higher Costs With IVC Filters in Catheter-Directed Thrombolysis for DVT

Michael O'Riordan

July 23, 2018

Navigating Vascular Access as a Cardiology Fellow

News Opinion Fellow Talk

Navigating Vascular Access as a Cardiology Fellow

Udit Bhatnagar, MD

July 12, 2018

News Industry News

Essential Medical Announces Positive Results from The Safe Manta Clinical Trial, The First Pivotal Trial for a Dedicated Large Bore Closure Device

June 25, 2018

SAFE-MANTA: Large-Bore Vascular Closure Device Achieves Fast Hemostasis with Few Complications

News Conference News The Structural Heart Disease Summit 2018

SAFE-MANTA: Large-Bore Vascular Closure Device Achieves Fast Hemostasis With Few Complications

Michael O'Riordan

June 23, 2018

News Industry News

Medtronic Receives FDA Approval for 200mm & 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons

June 18, 2018

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

News Features

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

June 08, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.